Enlivex Therapeutics Ltd. (ENLV)

Enlivex Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Enlivex Therapeutics stock has a target of 7.00, which predicts a 747.46% increase from the current stock price of 0.83.

Price Target: $7.00 (+747.46%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.00	$7.00	$7.00	$7.00
Change	+747.46%	+747.46%	+747.46%	+747.46%

* Price targets were last updated on Sep 2, 2025.

Analyst Ratings

The average analyst rating for Enlivex Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	2	2	2	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 24, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $13	Strong Buy	Maintains	$13	+1,473.85%	Oct 29, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $13	Strong Buy	Maintains	$13	+1,473.85%	Sep 26, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $13	Strong Buy	Maintains	$13	+1,473.85%	Sep 12, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+747.46%	Sep 2, 2025

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -0.53

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-0.90	-0.81	-1.69	-1.56	-0.73	-0.53	-0.59
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-0.47	-0.60
Avg	-0.53	-0.59
Low	-0.57	-0.58

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.